Navigation Links
BUSM awarded NIH grant to identify role of immune system in chronic inflammation, disease

(Boston) A team of researchers at Boston University School of Medicine (BUSM) have been awarded a five-year, $7.7 million grant from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to explore how chronic inflammation can lead to systemic diseases. Caroline Genco, PhD, director of research in the section of infectious diseases and professor of medicine and microbiology at BUSM, is the principal investigator on the grant. She will lead a multidisciplinary research team as they study the cellular mechanisms responsible for immune system activation, which induces chronic inflammation following bacterial infection.

Inflammation, which is the body's biological response to infection, initiates the healing process. In most cases, infections with pathogens, including bacteria, result in attack by the immune system and clearance of the pathogen. However, certain types of bacteria persist in the body for long periods of time, causing sub acute chronic infections. During that time, they cause inflammation, which can lead to systemic diseases.

This study focuses on two pathogens, Chlamydophila pneumoniae and Porphyromanas gingivalis, which induce a chronic inflammatory response in the lungs and the mouth, respectively. The chronic inflammation can lead to atherosclerosis, or hardening of the arteries, as a result of plaque buildup.

"The goal of this study is to understand how these pathogens persist and cause inflammation that can eventually lead to disease," said Genco. "The immune system exists to protect us, yet in some circumstances, it has harmful effects and contributes to systemic inflammatory diseases. We are investigating what goes awry in this complex system so that we can identify what mechanisms are responsible for these detrimental health outcomes."

Other researchers at BUSM involved include Robin Ingalls, MD, Frank Gibson, PhD, Guillermo Madico, MD, PhD, and Lee Wetzler, MD, all from the section of infectious diseases; Jane Freedman, MD, and Ellen Weinberg, PhD, of Boston Medical Center's section of cardiology and vascular medicine; James Hamilton, PhD, from the department of physiology & biophysics at BUSM and biomedical engineering at Boston University's College of Engineering; and Michael Lavalley, PhD, of Boston University's School of Public Health.


Contact: Jenny Eriksen Leary
Boston University Medical Center

Related biology news :

1. Nationwide Childrens Hospital awarded $11.5 million contract extension for biospecimen banking
2. Acceleron awarded $1.5 million grant from Muscular Dystrophy Association to support ACE-031
3. Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction
4. SEBM European Best Poster Prize awarded at Annual Conference of the German Society for Gene Therapy
5. University of Illinois awarded National Science Foundation grant to mentor Latino students
6. Argonne scientists awarded supercomputing time to enable scientific breakthroughs
7. Arjun Deb awarded Louis N. and Arnold M. Katz Basic Science Research Prize
8. New Scripps Florida scientist awarded pair of unconventional grants
9. NIMHs Dr. Mortimer Mishkin to be awarded National Medal of Science
10. Aeras awarded €11.7 million ($16 million) grant from Dutch government
11. Mississauga teacher awarded prize for excellence in teaching genomics
Post Your Comments:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology: